BRPI0411985A - treatment of sexual dysfunction - Google Patents
treatment of sexual dysfunctionInfo
- Publication number
- BRPI0411985A BRPI0411985A BRPI0411985-1A BRPI0411985A BRPI0411985A BR PI0411985 A BRPI0411985 A BR PI0411985A BR PI0411985 A BRPI0411985 A BR PI0411985A BR PI0411985 A BRPI0411985 A BR PI0411985A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- sexual dysfunction
- sexual
- dysfunction
- disorder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Abstract
"TRATAMENTO DA DISFUNçãO SEXUAL". A presente invenção refere-se com a utilização de inibidores de guanosina-3<39>,5<39>-monofosfato cíclico-fosfodiesterase de tipo cinco (PDE5), associados a agonistas de 5HT1a para o tratamento de disfunção sexual, em particular do distúrbio da excitação sexual feminina (FSAD) com distúrbio do desejo sexual hipoativo (HSDD) concomitante."Treatment of Sexual Dysfunction". The present invention relates to the use of guanosine-3 ?, 5? -Cyclic monophosphate-phosphodiesterase type five (PDE5) inhibitors, combined with 5HT1a agonists for the treatment of sexual dysfunction, in particular the treatment of sexual dysfunction. female sexual arousal disorder (FSAD) with concomitant hypoactive sexual desire disorder (HSDD).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0316673A GB0316673D0 (en) | 2003-07-16 | 2003-07-16 | Treatment of female sexual dysfunction |
GB0318095A GB0318095D0 (en) | 2003-08-01 | 2003-08-01 | Treatment of sexual dysfunction |
GB0321308A GB0321308D0 (en) | 2003-09-11 | 2003-09-11 | Treatment of sexual dysfunction |
PCT/IB2004/002286 WO2005007166A1 (en) | 2003-07-16 | 2004-07-12 | Treatment of sexual dysfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0411985A true BRPI0411985A (en) | 2006-08-29 |
Family
ID=34084177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0411985-1A BRPI0411985A (en) | 2003-07-16 | 2004-07-12 | treatment of sexual dysfunction |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1653966A1 (en) |
JP (1) | JP2007516949A (en) |
BR (1) | BRPI0411985A (en) |
CA (1) | CA2532252A1 (en) |
MX (1) | MXPA06000623A (en) |
TW (1) | TW200505410A (en) |
WO (1) | WO2005007166A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
AR048128A1 (en) * | 2003-12-01 | 2006-04-05 | Akzo Nobel Nv | A TREATMENT OF SEXUAL DIFUNCTION |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
MXPA06012059A (en) * | 2004-04-22 | 2007-01-25 | Boehringer Ingelheim Int | New pharmaceutical compositions for the treatment of sexual disorders ii. |
CA2566699C (en) | 2004-05-11 | 2016-02-16 | Emotional Brain B.V. | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
EP1945214A1 (en) * | 2005-10-29 | 2008-07-23 | Boehringer Ingelheim International GmbH | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
EP1790343A1 (en) | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction |
WO2008117269A2 (en) | 2007-03-28 | 2008-10-02 | Atir Holding S.A. | Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof |
CA2649938A1 (en) * | 2006-05-09 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
ATE456369T1 (en) | 2006-06-30 | 2010-02-15 | Boehringer Ingelheim Int | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES |
CL2007002214A1 (en) | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | PHARMACEUTICAL COMPOSITION IN THE FORM OF COMPRESSED, WHERE AT LEAST THE LENGTH OF THE COMPRESSED IN THE PREVIOUS STATE OF THE APPLICATION IS AT LEAST 7/12 OF THE PILOR DIAMETER OF THE PATIENT AND AFTER INGERING IT IN THE FOOD STATE, THE LENGTH OF THE COMP |
WO2008019996A2 (en) | 2006-08-14 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
MX2009002031A (en) | 2006-08-25 | 2009-03-06 | Boehringer Ingelheim Int | Controlled release system and method for manufacturing the same. |
EP1925307A1 (en) * | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Use of 3-alpha-androstanediol in the treatment of sexual dysfunction |
CL2008002693A1 (en) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability |
EP2695932A1 (en) | 2012-08-08 | 2014-02-12 | Ab Nanol Technologies Oy | Grease composition |
JP2021535195A (en) * | 2018-08-07 | 2021-12-16 | アイエルワイエルティー・エルエルシーIlylt, Llc | Compositions and Methods for Treating Sexual Dysfunction and Enhancing Sexual Response and Pleasure |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055070A1 (en) * | 1999-07-01 | 2003-03-20 | Wilma Harrison | Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selective serotonin reuptake inhibitor (SSR) induced sexual dysfunction |
US20020052370A1 (en) * | 2000-07-06 | 2002-05-02 | Barber Christopher Gordon | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
GB0105893D0 (en) * | 2001-03-09 | 2001-04-25 | Pfizer Ltd | Pharmaceutically active compounds |
GB0106446D0 (en) * | 2001-03-15 | 2001-05-02 | Vernalis Res Ltd | Chemical compounds |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
GB0225908D0 (en) * | 2002-11-06 | 2002-12-11 | Pfizer Ltd | Treatment of female sexual dysfunction |
-
2004
- 2004-07-12 EP EP04743948A patent/EP1653966A1/en not_active Withdrawn
- 2004-07-12 WO PCT/IB2004/002286 patent/WO2005007166A1/en active Application Filing
- 2004-07-12 MX MXPA06000623A patent/MXPA06000623A/en not_active Application Discontinuation
- 2004-07-12 JP JP2006520035A patent/JP2007516949A/en active Pending
- 2004-07-12 BR BRPI0411985-1A patent/BRPI0411985A/en not_active IP Right Cessation
- 2004-07-12 CA CA002532252A patent/CA2532252A1/en not_active Abandoned
- 2004-07-15 TW TW093121146A patent/TW200505410A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA06000623A (en) | 2006-04-11 |
WO2005007166A1 (en) | 2005-01-27 |
TW200505410A (en) | 2005-02-16 |
CA2532252A1 (en) | 2005-01-27 |
EP1653966A1 (en) | 2006-05-10 |
JP2007516949A (en) | 2007-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0411985A (en) | treatment of sexual dysfunction | |
ECSP077421A (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE ACTIVITY OF THE CANABINOID RECEIVER 1 | |
CY1120741T1 (en) | TREATMENT OF NOSE SCRUB | |
MX2010000098A (en) | Polycyclic guanine derivatives and use thereof. | |
NO20085099L (en) | Puriton derivatives such as HM74A agonists | |
NO20072558L (en) | Mitotic kinase inhibitors and methods for their use | |
CL2008002207A1 (en) | Pharmaceutical composition comprising immunosuppressants to improve the effect in the use of an antagonist of interleukin-6 (il-6) for the treatment of illnesses related to il-6 (div. Sol. 896-04). | |
PH12014501440A1 (en) | Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction | |
BR122019021238B8 (en) | use of an interleukin-6 (il-6) receptor inhibitor in the treatment of graft versus host disease (gvhd) | |
ECSP11010975A (en) | METHOD OF USE OF A BACILLUS SUBTILIS CEPA TO IMPROVE ANIMAL HEALTH | |
EA201491697A1 (en) | COMPOSITIONS OF GUANYLATZIKLAZY AGONISTS AND METHODS OF APPLICATION | |
UY29899A1 (en) | USE OF FLIBANSERINE FOR THE TREATMENT OF PREMENOPAUSIC SEXUAL DESIRE DISORDERS | |
EA200870425A1 (en) | APPLICATION OF GRP119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS AND RELATED COMBINED THERAPY | |
MX2010004219A (en) | Cd19 binding agents and uses thereof. | |
EA201170288A1 (en) | OXABICYCLOPTANES AND OXABICYCLOPTENS | |
EA201170252A1 (en) | AMIDOPHENOXINDAZOLES AS C-MET INHIBITORS | |
EA200970737A1 (en) | OXABICYCLOPTANES AND OXABICYCLOPTENS | |
EA200701979A1 (en) | METHOD FOR OBTAINING OPIOID MODULATORS | |
EA200601074A1 (en) | APPLICATION OF DERIVATIVE PEPTIDES FOR THE TREATMENT OF PAINS ASSOCIATED WITH THE DISEASE OF THE CENTRAL NERVOUS SYSTEM (CENTRAL NEUROPATHIC PAIN) | |
CL2009000402A1 (en) | Substituted 2-amino-acetamide derived compounds; pharmaceutical composition; Useful in the treatment of lung diseases, rheumatic disease, autoimmune disease, among others. | |
GT200600442A (en) | PDE INHIBITORS AND COMBINATIONS OF THE SAME FOR THE TREATMENT OF UROLOGICAL DISORDERS | |
AR113492A2 (en) | RECOMBINANT FURIN FREE OF SUBSTANTIALLY ANIMAL PROTEINS AND METHODS TO PRODUCE IT | |
CL2008001074A1 (en) | Use of triazole compounds, smo antagonists to treat cancer. | |
GB2464240A (en) | Unitary Hair Clip and Method of Use | |
NO20076186L (en) | Mitotic kinesin inhibitors and methods for their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |